Pharma & Biotech

The markets are behaving in a manner that defies conventional wisdom regarding InnoCan Pharma. Typically, significant positive developments propel a...

Danish pharmaceutical giant Novo Nordisk faces a significant strategic challenge following the disappointing outcome of its highly anticipated Alzheimer's treatment...

A prolonged period of negotiations and strategic maneuvering within the German biotech sector has culminated in a definitive resolution. Shareholders...

Halozyme Therapeutics finds itself at a pivotal moment as it navigates a significant executive transition against a backdrop of exceptional...

The biotechnology sector is witnessing notable momentum in Cellectar Biosciences, with the company's stock demonstrating substantial upward movement following significant...

CureVac investors have officially cleared the path for the company's acquisition by vaccine developer BioNTech, bringing months of anticipation to...

Recent activity at Cassava Sciences reveals a compelling narrative of executive confidence and strategic financial positioning. The biotechnology firm's leadership...

Pfizer is making significant strides in reshaping its post-pandemic trajectory, with recent clinical trial results generating substantial excitement among investors....

Shares of Hims & Hers Health experienced a significant rally, climbing nearly 9% following the company's announcement of a major...

A curious divergence defines the current situation for Bionxt Solutions. The company continues to hit significant operational targets, yet its...